-The Telegraph With the funds blocked, I’ve been unable to pay some suppliers who want to be paid before they supply again, says a scientist Dozens of scientists who had been invited from positions abroad to join academic institutions across India under a prestigious government fellowship have not received research grants or salaries for months, the fellows and other scientists have said. The delay in the release of funds for the Ramalingaswami Fellowships,...

-The Hindu Business Line The laws concerned are riddled with loopholes. A mandatory, enforceable code for ethical pharmaceutical marketing is a must The recent kerfuffle over a particular brand of the painkiller paracetamol 650 mg tablet is not really over the particular brand as much as about the unethical marketing tactics of the pharmaceutical industry in India. Gone are the days when a mere ball-point pen or a diary from a medical representative...

-Down to Earth Undergoing hysterectomy at younger ages can have adverse health impacts including osteoporosis and cardiovascular diseases The rise in cases of hysterectomy or the surgical procedure for uterus removal in India has been a cause of concern in recent years, with critics complaining that doctors are too quick to take out the uterus at the smallest sign of trouble. While it is difficult to gauge the actual extent of the problem...

-Down to Earth No regulation on marketing strategies by drug companies has created a medical autocracy, the Dolo-650 controversy shows If you had to take paracetamol 650 milligrams instead of paracetamol 500 mg three times a day during the COVID-19 pandemic, you may be familiar with the drug called Dolo-650. The drug is prescribed for reducing fever and pain, but the medicine possibly reached you thanks to its manufacturer’s market strategy. A petition...

-TheWire.in The petition alleged that to ensure a higher profit margin, the company manufacturing Dolo tablets distributed freebies to doctors to prescribe the 650 mg drug.  New Delhi: The Supreme Court Thursday, August 18 was told by an NGO that the Central Board of Direct Taxes (CBDT) has accused the pharma company manufacturing paracetamol drug ‘Dolo’ of distributing Rs 1,000 crore freebies to doctors for prescribing a dosage of its 650 mg...